More bipolar patients will be getting lithium

December 2003

More bipolar patients will be getting lithium.

Both lithium and valproate are considered first-line mood stabilizers for most patients with bipolar disorder.

Lithium use has decreased over the years, mainly due to monitoring requirements...bothersome side effects...and the use of valproate and newer drugs for bipolar disorder.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

now recommend AGAINST keeping ipecac syrup on hand for accidental poisonings
Cardiology Reports in the lay press are suggesting that it's dangerous for patients to stop low-dose aspirin
Cardiology valsartan (Diovan) improves survival after a heart attack
Gastroenterology confusion about the new OTC version of Prilosec
Cholesterol food products marketed as "heart healthy"
Cholesterol Which statins should to be taken in the evening?
Neurology & Pain whether opiates cause hearing loss
Antidepressants New alternatives to Paxil are hitting the market
Antidepressants More stroke patients are now getting an antidepressant
Asthma Is it necessary to taper a short course of oral corticosteroids?
More bipolar patients will be getting lithium
Risperdal Consta will be the first LONG-ACTING injectable ATYPICAL antipsychotic
Psoriasis Raptiva for psoriasis
Women's Health new Rx estrogen cream, Estrasorb
Medication Errors eliminate dangerous abbreviations from prescriptions
Anticoagulants new oral anticoagulant called Exanta (ximelagatran, zye-mel-a-GAT-ran)
Practice Cialis (tadalafil), the new long-acting drug for erectile dysfunction

More bipolar patients will be getting lithium

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents